Synthesis and evaluation of novel 18F-labeled spirocyclic piperidine derivatives as σ1 receptor ligands for positron emission tomography imaging

Yan Li,Xia Wang,Jinming Zhang,Winnie Deuther-Conrad,Fang Xie,Xiaojun Zhang,Jian Liu,Jinping Qiao,Mengchao Cui,Jörg Steinbach,Peter Brust,Boli Liu,Hongmei Jia
DOI: https://doi.org/10.1021/jm301734g
IF: 8.039
2013-01-01
Journal of Medicinal Chemistry
Abstract:A series of spirocyclic piperidine derivatives were designed and synthesized as sigma(1) receptor ligands. In vitro competition binding assays showed that 1'-(4-(2-fluoroethoxy)benzyl)-3H-spiro[2-benzofuran-1,4'-pipericline] (19) possessed high sigma(1) receptor affinity (K-i = 0.79 nM) and excellent sigma(1)/sigma(2) subtype selectivity (350-fold) as well as high sigma(1)/VAChT selectivity (799-fold). The radiolabeled compound [F-18]19 was synthesized by substitution of the tosylate precursor 24 with [F-18]fluoride, with an isolated radiochemical yield of 35-60%, a radiochemical purity of >99%, and a specific activity of 30-55 GBq/mu mol. Biodistribution studies in imprinting control region mice indicated that [F-18] 19 displayed excellent initial brain uptake and slow washout. Ex vivo autoradiography in Sprague Dawley rats demonstrated high accumulation of the radiotracer in brain areas known to express high levels of sigma(1) receptors. Micro positron emission tomography imaging and blocking studies confirmed the specific binding of [F-18] 19 to sigma(1) receptors in vivo.
What problem does this paper attempt to address?